Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diltiazem for COVID-19 Pneumonia
NCT05563168Phase 2Withdrawn
- Sponsor
- Hospices Civils de Lyon
- Start
- Apr 2023
- Primary completion
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of diltiazem in COVID-19 pneumonia, sponsored by Hospices Civils de Lyon. Planned start Apr 2023; status: withdrawn.
02
Drugs
diltiazem
03
Conditions
COVID-19 pneumonia
Beyond the preview
Go deeper on NCT05563168.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05563168.